nach oben

Current Infectious Disease Reports

Erschienen in:

01.04.2016 | Pediatric Infectious Diseases (I Brook, Section Editor)

Pyomyositis in Children

verfasst von: Sanjay Verma

Erschienen in: Current Infectious Disease Reports | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Primary pyomyositis in children is prevalent in the tropics and increasingly being recognised from temperate regions. Staphylococcus aureus remains the principle causative organism worldwide, while proportion of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) is on rise. Commonly involved groups are around the pelvis and lower limbs. Clinical presentation depends on the stage of disease, most commonly a child presenting with limping with fever. Early diagnosis and management are crucial. The investigation of choice is MRI scan. Appropriate antibiotic treatment should be instituted at the earliest opportunity along with drainage. Majority of patients show excellent and complete recovery with no long-term complications once treatment is started early. A high level of awareness and suspicion of this condition is warranted from all paediatric clinicians.

Scriba J, Beitrang Z. Aetiologie der myositis acuta. Deutsche Zeit Chir. 1885;22:497–502.CrossRef

Miyake H. Beitragezurkenntnis der sogenannten myositis infectiosa. Mitt Grenageb Med Chir. 1904;13:155–98.

Ashken MH, Cotton RE. Tropical skeletal muscle abscesses (pyomyositis tropicans). Br J Surg. 1963;50:846–52.CrossRefPubMed

4.••

Groose C. Bacterial myositis and pyomyositis. In: Cherry JD, Harrison GJ, Kaplan SL, Steinbach WJ, Hotez PJ, editors. Feigin and Cherry’s textbook of pediatric infectious diseases. 7th ed. Philadelphia: Elesvier Saunders; 2014. This article shows us the epidemiology of pyomyositis in world, one of the most useful reviews on pyomyositis published in textbook of pediatric infectious diseases.

5.•

Verma S, Singhi SC, Marwaha RK, et al. Tropical pyomyositis in children: 10 years experience of a tertiary care hospital in northern India. J Trop Pediatr. 2013;59(3):243–5. One of the biggest case series from India about tropical pyomyositis in pediatric age group.CrossRefPubMed

Gambhir IS, Singh DS, Gupta SS, Gupta PR, Kumar M. Tropical pyomyositis in India: a clinico-histopathological study. J Trop Med Hyg. 1992;95(1):42–6.PubMed

Malhotra P, Singh S, Sud A, et al. Tropical pyomyositis-experience of a tertiary care hospital in North West India. J Assoc Physicians India. 2000;48:1057–60.PubMed

Chauhan S, Kumar R, Singh KK, Chauhan SS. Tropical pyomyositis: a diagnostic dilemma. J Ind Acad Clin Med. 2004;5:52–4.

Chauhan S, Jain S, Varma S, Chauhan SS. Tropical pyomyositis (myositis tropicans): current prospective. Postgrad Med J. 2004;80:267–70.CrossRefPubMedPubMedCentral

10.

Christin L, Sarosi GA. Pyomyositis in North America: case reports and review. Clin Infect Dis. 1992;15:668–77.CrossRefPubMed

11.

Gibson RK, Rosenthal SJ, Lukert BP. Pyomyositis. Increasing recognition in temperate climates. Am J Med. 1992;77:768–72.CrossRef

12.

Hall RI, Callaghan JJ, Moloney E, et al. Pyomyositis in a temperate climate. Presentation, diagnosis, and treatment. J Bone Joint Surg Am. 1990;72:1240–4.PubMed

13.••

Moriarty, Leung C, Walsh M, Nourse C. Increasing pyomyositis presenting among children in Queensland, Australia. Pediatr Infect Dis J. 2015;34(1):1–4. Recent report of increasing incidence of pyomyositis from Australia.CrossRefPubMed

14.•

Unnikrishnan PN, Perry DC, George H, Bassi R, Bruce CE. Tropical primary pyomyositis in children of the UK: an emerging medical challenge. Int Orthop. 2010;34:109–13. Recent report of pyomyositis from UK, showing prevalence in United Kingdom.CrossRefPubMedPubMedCentral

15.

Gubbay AJ, Isaacs D. Pyomyositis in children. Pediatr Infect Dis J. 2000;19(10):1009–12.CrossRefPubMed

16.

Spiegel DA, Meyer JS, Dormans JP, Flynn JM, Drummond DS. Pyomyositis in children and adolescents: report of 12 cases and review of the literature. J Pediatr Orthop. 1999;19(2):143–50.CrossRefPubMed

17.

Horn CV, Master S. Pyomyositis tropicans in Uganda. E Afr Med J. 1968;45(7):463–71.

18.

Smith MI, Vickers AB. Natural history of 338 treated and untreated patients with staphylococcal septicaemia (1936–1955). Lancet. 1960;1(7138):1318–22.CrossRefPubMed

19.

Jayoussi R, Bialik V, Eyal A, Shehadeh N, Etzioni A. Pyomyositis caused by vigorous exercise in a boy. Acta Paediatr. 1995;84(2):226–7.CrossRefPubMed

20.

Singh SB, Singh VP, Gupta S, Gupta RM, Sunder S. Tropical myositis: a clinical, immunological and histopathological study. J Assoc Physicians India. 1989;37(9):561–3.PubMed

21.•

Pannaraj PS, Hulten KG, Gonzalez BE, Mason Jr EO, Kaplan SL. Infective pyomyositis and myositis in children in the era of community-acquired, methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis. 2006;43:953–60. This article emphasizes the changing epidemiology of causative organisms of tropical pyomyositis.CrossRefPubMed

22.•

Mitchell PD, Hunt DM, Lyall H, Nolam M, et al. Panton-Valentine leukocidin-secreting Staphylococcus aureus causing sever musculoskeletal sepsis in children. A new threat. J Bone Joint Surg (Br). 2007;89:1239–42. This articles shows us the association of PVL genes with pyomyositis.CrossRef

23.•

Yamaguchi T, Nakamura I, Chiba K, Matsumoto T. Epidemiological and microbiological analysis of community-associated methicillin-resistant Staphylococcus aureus strains isolated from a Japanese hospital. Jpn J Infect Dis. 2012;65(2):175–8. This article is one of the biggest reviews on pyomyositis in Japanese population.PubMed

24.•

Lall M, Sahni AK. Prevalence of inducible clindamycin resistance in Staphylococcus aureus isolates from clinical samples. Med J Armed Forces India. 2014;70(1):43–7. This article state the increasing prevalence of clindamycin resistance in staphylococcus aureus.CrossRefPubMedPubMedCentral

25.

Diamandakis V, Grose C. Bad consequences of bicycle accidents. Pyomyositis. Pediatr Infect Dis J. 1994;13(5):422–5.CrossRefPubMed

26.

Giasuddin AS, Idoko JA, Lawande RV. Tropical pyomyositis: is it an immunodeficiency disease? Am J Trop Med Hyg. 1986;35(6):1231–4.PubMed

27.

Ladipo GO, Fakunle YF. Tropical pyomyositis in the Nigerian Savanna. Trop Geogr Med. 1977;29(3):223–8.PubMed

28.

Crum-Cianflone NF. Infection and musculoskeletal conditions: infectious myositis. Best Pract Res Clin Rheumatol. 2006;20:1083–97.CrossRefPubMed

29.•

Hadjipavlou M, Butt DA, McAllister J. Primary pyomyositis: an unusual presentation in an older patient with no recognised risk factors. BMJ Case Rep. 2012. doi:10.1136/bcr.12.2011.5342. This article emphasizes that pyomyositis is possible even in person without any risk factors.PubMedPubMedCentral

30.

Meehan J, Grose C, Soper RT, Kimura K. Pyomyositis in an adolescent female athlete. J Pediatr Surg. 1995;30(1):127–8.CrossRefPubMed

31.

Chiedozi LC. Pyomyositis. Review of 205 cases in 112 patients. Am J Surg. 1979;137:255–9.CrossRefPubMed

32.

Borges AH, Faragher B, Lalloo DG. Pyomyositis in the upper Negro river basin, Brazilian Amazonia. Trans R Soc Trop Med Hyg. 2012;106(9):532–7.CrossRefPubMed

33.•

Chiu NC, Hsieh MC, Chi H, Huang FY. Clinical characteristics of pyomyositis in children: 20-year experience in a medical centre in Taiwan. J Microbiol Immunol Infect. 2009;42(6):494–9. Recent articles stating pyomyositis in hip area in children.PubMed

34.

Tanir G, Tonbul A, Tuygun N, Aydemir C, Ertan U. Soft tissue infections in children: a retrospective analysis of 242 hospitalized patients. Jpn J Infect Dis. 2006;59(4):258–60.PubMed

35.

Bertrand SL, Lincoln ED, Prohaska MG. Primary pyomyositis of the pelvis in children: a retrospective review of 8 cases. Orthopedics. 2011;34(12):832–40.

36.

Mitsionis G, Manoudis GN, Lykissas MG, Sionti I, Motsis E, Georgoulis AD, et al. Pyomyositis in children: early diagnosis and treatment. J Pediatr Surg. 2009;44(11):2173–8.CrossRefPubMed

37.

Brook I. Pyomyositis in children, caused by anaerobic bacteria. J Pediatr Surg. 1996;31(3):394–8.CrossRefPubMed

38.

Garcia-Mata S, Hidalgo-Ovejero A, Esparza-Estaun J. Primary obturator-muscle pyomyositis in immunocompetent children. J Child Orthop. 2012;6:205–15.CrossRefPubMedPubMedCentral

39.•

Mignemi ME, Menge TJ, Cole HA, et al. Epidemiology, diagnosis, and treatment of pericapsular pyomyositis of the hip in children. J Pediatr Orthop. 2014;34(3):316–25. Articles emphasizing role of imaging in diagnosing pyomyositis.CrossRefPubMed

40.••

Leuthauser A, Paul A. Hip pain and fever: when it’s not a septic joint, what’s next? Pediatr Emerg Care. 2015;31(1):42–3. This report emphasizing cases of spinal pyomyositis and role of imaging.CrossRefPubMed

41.

Solar R, Rodriguez E, Aguiler C, Fernandez R. Magnetic resonance imaging of pyomyositis in 43 cases. Eur J Radiol. 2000;35(1):59–64.CrossRef

42.

Trusen A, Beissert M, Schultz G, Darge K. Ultrasound and MRI features of pyomyositis in children. Eur Radiol. 2003;13(5):1050–5.PubMed

43.

Moran GG, Duran CG, Albinana J. Imaging on pelvic pyomyositis in children related to pathogenesis. J Child Orthop. 2009;3:479–84.CrossRef

44.

Adamski GB, Garin EH, Ballinger WE, et al. Generalized non-suppurative myositis with staphylococcal septicemia. J Pediatr. 1980;96:694–7.CrossRefPubMed

45.•

Boulyana M, Kilani MS. Nontropical pyomyositis complicated with spinal epidural abscess in a previously healthy child. Surg Neurol Int. 2014;5:119–21. Article emphasizing role of clindamycin in treatment of pyomyositis.CrossRef

46.•

Vander Have KL, Karmazyn B, Verma M, et al. Community-associated methicillin-resistant Staphylococcus aureus in acute musculoskeletal infection in children: a game changer. J Pediatr Orthop. 2009;29(8):927–31. Article explaining eagle effect in management of staphylococcal infections.CrossRefPubMed

47.

Brickels J, Ben-Sira L, Kessler A, Wientroub S. Primary pyomyositis. J Bone Joint Surg Am. 2002;84:2277–86.

48.•

Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 1999;18:1096–100. This article showing anaerobes to be causative organism for pyomyositis.CrossRefPubMed

49.

Svetitsky S, Leibovic L, Paul M. Comparative efficacy and safety of vancomycin versus teicoplanin. Antimicrob Agents Chemother. 2009;53(10):4069–79.CrossRefPubMedPubMedCentral

50.

Stevens DL, Gibbons AE, Bergstrom R, Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988;158:23–8.CrossRefPubMed

51.

Hudson IR. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience. J Hosp Infect. 1994;27:81–98.CrossRefPubMed

Titel: Pyomyositis in Children
verfasst von: Sanjay Verma
Publikationsdatum: 01.04.2016
Verlag: Springer US
Erschienen in: Current Infectious Disease Reports / Ausgabe 4/2016
Print ISSN: 1523-3847
Elektronische ISSN: 1534-3146
DOI: https://doi.org/10.1007/s11908-016-0520-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen